Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07WGN
|
|||
| Drug Name |
DP9
|
|||
| Synonyms |
IUFRDGFKAVLPFZ-CSMHCCOUSA-N; CHEMBL228077; L-N(OMEGA)-NITROARGININE-(4R)-AMINO-L-PROLINE AMIDE; CHEMBL161297; (2S,4R)-4-[(2S)-2-amino-5-(1-nitrocarbamimidamido)pentanamido]pyrrolidine-2-carboxamide; AC1LCVP2; JMC522060 Compound 3; SCHEMBL14123722; BDBM21961; BDBM50138976; BDBM50072408; DB02077; N omega-Nitro-L-Arginine-Containing Dipeptide, 2; (2S,4R)-4-[[(2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoyl]amino]pyrrolidine-2-carboxamide; (2S)-4-[((2S)-2-amino-5-{[(E)-imino(nitroamino)methyl]amino}pentanoyl)amino]pyrrolidine-2-carboxam
Click to Show/Hide
|
|||
| Indication | Myocardial ischemia [ICD-11: BA6Z; ICD-10: I20-I25; ICD-9: 410, 459.89] | Phase 2 | [1] | |
| Company |
Dimera Portland, OR
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C11H22N8O4
|
|||
| Canonical SMILES |
C1C(CNC1C(=O)N)NC(=O)C(CCCN=C(N)N[N+](=O)[O-])N
|
|||
| InChI |
1S/C11H22N8O4/c12-7(2-1-3-15-11(14)18-19(22)23)10(21)17-6-4-8(9(13)20)16-5-6/h6-8,16H,1-5,12H2,(H2,13,20)(H,17,21)(H3,14,15,18)/t6-,7+,8+/m1/s1
|
|||
| InChIKey |
IUFRDGFKAVLPFZ-CSMHCCOUSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.